750
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Clinical Oncology

Liver cancer risk quantification through an artificial neural network based on personal health data

, & ORCID Icon
Pages 495-502 | Received 18 Jan 2023, Accepted 09 May 2023, Published online: 21 May 2023

References

  • Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
  • Singh GK, Siahpush M, Altekruse SF. Time trends in liver cancer mortality, incidence, and risk factors by unemployment level and race/ethnicity, United States, 1969–2011. J Community Health. 2013;38(5):926–940.
  • Momin B, Richardson L. An analysis of content in comprehensive cancer control plans that address chronic hepatitis B and C virus infections as major risk factors for liver cancer. J Community Health. 2012;37(4):912–916.
  • Mimi CY, Yuan J-M. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology. 2004;127(5 Suppl 1):S72–S78.
  • Blaes A, Prizment A, Koene RJ, et al. Cardio-oncology related to heart failure: common risk factors between cancer and cardiovascular disease. Heart Fail Clin. 2017;13(2):367–380.
  • Singh S, Fujii LL, Murad MH, et al. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(12):1573.e2–1584.e2.
  • Azzalini L, Ferrer E, Ramalho LN, et al. Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology. 2010;51(5):1567–1576.
  • Carter BD, Abnet CC, Feskanich D, et al. Smoking and mortality—beyond established causes. N Engl J Med. 2015;372(7):631–640.
  • Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348(17):1625–1638.
  • Bangalore S, Kumar S, Kjeldsen SE, et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials. Lancet Oncol. 2011;12(1):65–82.
  • González CA, Jakszyn P, Pera G, et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst. 2006;98(5):345–354.
  • Kao J-H, Chen D-S. Recent research progress in hepatocellular carcinoma. J Formos Med Assoc. 2002;101(4):239–248.
  • Yu MC, Yuan J-M, Govindarajan S, et al. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol. 2000;14(8):703–709.
  • Koh WP, Robien K, Wang R, et al. Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese health study. Br J Cancer. 2011;105(9):1430–1435.
  • Koh W-P, Yuan J-M, Sun C-L, et al. Middle-aged and older Chinese men and women in Singapore who smoke have less healthy diets and lifestyles than nonsmokers. J Nutr. 2005;135(10):2473–2477.
  • El-Zayadi A-R. Heavy smoking and liver. World J Gastroenterol. 2006;12(38):6098–6101.
  • Zhang X-F, Wei T, Liu X-M, et al. Impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis B. PLOS One. 2014;9(1):e85077.
  • Hammond EC. Smoking in relation to the death rates of one million men and women. Natl Cancer Inst Monogr. 1966;19:127–204.
  • Hirayama T. A large-scale cohort study on risk factors for primary liver cancer, with special reference to the role of cigarette smoking. Cancer Chemother Pharmacol. 1989;23(S1):S114–S117.
  • Lee Y-CA, Cohet C, Yang Y-C, et al. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. Int J Epidemiol. 2009;38(6):1497–1511.
  • Chen Y-Y, Lin Y-H, Kung C-C, et al. Design and implementation of cloud analytics-assisted smart power meters considering advanced artificial intelligence as edge analytics in demand-side management for smart homes. Sensors. 2019;19(9):2047.
  • Jiang F, Jiang Y, Zhi H, et al. Artificial intelligence in healthcare: past, present and future. Stroke Vasc Neurol. 2017;2(4):230–243.
  • Smith JW, Everhart JE, Dickson WC, et al. Using the ADAP learning algorithm to forecast the onset of diabetes mellitus. Proc Annu Symp Comput Appl Med Care. 1988:261–265.
  • Salim N. Medical diagnosis using neural network. Faculty of Information Technology, University of Utara Malaysia; 2004.
  • Patil SM, Mudholkar RR. An osteoarthritis classifier using back propagation neural network. Int J Adv Eng Technol. 2012;4(2):292.
  • Shahid N, Rappon T, Berta W. Applications of artificial neural networks in health care organizational decision-making: a scoping review. PLOS One. 2019;14(2):e0212356.
  • Waring J, Lindvall C, Umeton R. Automated machine learning: review of the state-of-the-art and opportunities for healthcare. Artif Intell Med. 2020;104:101822.
  • Wolf E, Rich NE, Marrero JA, et al. Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta‐analysis. Hepatology. 2021;73(2):713–725.
  • Fujiwara N, Friedman SL, Goossens N, et al. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol. 2018;68(3):526–549.
  • Blewett LA, Rivera Drew JA, Griffin R, et al. IPUMS health surveys: national health interview survey, version 6.2. Minneapolis (MN): University of Minnesota. 2016. p. d070.
  • Kramer BS, Gohagan J, Prorok PC, et al. A national cancer institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Cancer. 1993;71(2 Suppl):589–593.
  • London WT, McGlynn KA. Liver cancer. Cancer Epidemiol Prev. 2006;3:763–786.
  • Yu L, Zhou R, Chen R, et al. Missing data preprocessing in credit classification: one-hot encoding or imputation? Emerg Mark Finance Trade. 2022;58(2):472–482.
  • Matsunaga Y. Accelerating SAT-based boolean matching for heterogeneous FPGAs using one-hot encoding and CEGAR technique. IEICE Trans Fundam Electron Commun Comput Sci. 2016; 99-A(7):1374–1380.
  • Huffman DA. The synthesis of sequential switching circuits. J Franklin Inst. 1954;257(3):161–190.
  • Muhammad W, Hart GR, Nartowt B, et al. Pancreatic cancer prediction through an artificial neural network. Front Artif Intell. 2019;2:2.
  • Hart GR, Roffman DA, Decker R, et al. A multi-parameterized artificial neural network for lung cancer risk prediction. PLoS One. 2018;13(10):e0205264.
  • Roffman DA, Hart GR, Leapman MS, et al. Development and validation of a multiparameterized artificial neural network for prostate cancer risk prediction and stratification. J Clin Oncol Clin Cancer Inform. 2018;2:1–10.
  • Hart GR, Yan V, Huang GS, et al. Population-based screening for endometrial cancer: human vs. machine intelligence. Front Artif Intell. 2020;3:539879.
  • Nartowt BJ, Hart GR, Roffman DA, et al. Scoring colorectal cancer risk with an artificial neural network based on self-reportable personal health data. PLOS One. 2019;14(8):e0221421.
  • Nartowt BJ, Hart GR, Muhammad W, et al. Robust machine learning for colorectal cancer risk prediction and stratification. Front Big Data. 2020;3(6):6.
  • Hart GR, Nartowt B, Muhammad W, et al. Stratifying ovarian cancer risk using personal health data. Front Big Data. 2019;2:24.
  • Campbell PT, Newton CC, Freedman ND, et al. Body mass index, waist circumference, diabetes, and risk of liver cancer for US adults. Cancer Res. 2016;76(20):6076–6083.
  • Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.
  • Harris PS, Hansen RM, Gray ME, et al. Hepatocellular carcinoma surveillance: an evidence-based approach. World J Gastroenterol. 2019;25(13):1550–1559.
  • Lin OS, Keeffe EB, Sanders GD, et al. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Aliment Pharmacol Ther. 2004;19(11):1159–1172.
  • Arguedas MR, Chen VK, Eloubeidi MA, et al. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol. 2003;98(3):679–690.
  • Yuen M-F, Tanaka Y, Fong DY-T, et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol. 2009;50(1):80–88.
  • Wong VW-S, Chan SL, Mo F, et al. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. J Clin Oncol. 2010;28(10):1660–1665.
  • Wong GL-H, Chan HL-Y, Wong CK-Y, et al. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B. J Hepatol. 2014;60(2):339–345.
  • Ma X, Yang Y, Tu H, et al. Risk prediction models for hepatocellular carcinoma in different populations. Chin J Cancer Res. 2016;28(2):150–160.
  • Lai Q, Spoletini G, Mennini G, et al. Prognostic role of artificial intelligence among patients with hepatocellular cancer: a systematic review. World J Gastroenterol. 2020;26(42):6679–6688.
  • Rubin DB. Statistical matching using file concatenation with adjusted weights and multiple imputations. J Bus Econ Stat. 1986;4(1):87–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.